Private company
Cyclo Therapeutics, Inc.
American biological products company, incorporated in Nevada.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Research and development100¢$14.2M
Out of $1.1M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.2M4 | $1.0M5 | $1.0M6 | $903.4K7 | $1.6M8 | $1.4M3 | $1.1M3 |
| Cost of revenue | $132.9K4 | $105.0K4 | |||||
| Gross profit | $1.2M3 | $992.0K3 | |||||
| Research and development | $2.3M4 | $2.7M5 | $4.9M6 | $6.1M7 | $9.2M8 | $9.0M3 | $14.2M3 |
| Operating income | -$3.8M4 | -$4.3M5 | -$7.5M6 | -$9.0M7 | -$14.3M8 | -$15.6M3 | -$20.1M3 |
| Interest | |||||||
| Income tax | $04 | $05 | $06 | $07 | $08 | $03 | $03 |
| Net income | -$3.8M4 | -$4.3M5 | -$7.5M6 | -$8.9M7 | -$14.3M8 | -$15.5M3 | -$20.1M3 |
| Earnings per share | -$2.248 | -$1.833 | -$1.233 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $1.3M5 | $2.2M5 | $2.8M6 | $12.8M7 | $16.6M8 | $1.5M3 | $9.2M3 |
| Current assets | $1.9M4 | $2.8M5 | $4.0M6 | $14.1M7 | $19.4M8 | $4.2M3 | $12.3M3 |
| Total assets | $2.1M4 | $2.9M5 | $4.1M6 | $14.2M7 | $19.5M8 | $4.2M3 | $13.2M3 |
| Current liabilities | $1.9M5 | $3.1M6 | $3.7M7 | $3.8M8 | $3.5M3 | $8.5M3 | |
| Long-term debt | |||||||
| Shareholders’ equity | $1.1M5 | $992.5K6 | $936.0K7 | $10.5M8 | $15.7M3 | $734.5K3 | $4.8M3 |
| Shares outstanding | 73.0M shares4 | 90.8M shares5 | 1.2M shares6 | 4.8M shares7 | 8.4M shares8 | 8.5M shares3 | 28.6M shares3 |
Leadership
Who has led Cyclo Therapeutics, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerN. Scott Fine Jun 8, 2016 to Jun 5, 202412
- Chief executive officerCe Rick Strattan Oct 28, 2010 to Jul 13, 201213
- Chief financial officerJoshua M. Fine Jun 21, 2019 to Jun 5, 202414
Board members and other officers (14)
- Chief Medical OfficerLise Lund Kjems Sep 28, 2021 to Mar 10, 202315
- Chief Regulatory OfficerMichael Eric Lisjak Sep 24, 2020 to Jun 5, 202416
- Executive Vice PresidentGeorge L. Fails Jul 26, 2016 to Jul 26, 201617
- Board memberWilliam Conkling May 8, 2023 to Mar 3, 202518
- Board memberVivien Wong Aug 21, 2023 to Mar 3, 202519
- Board memberShawn Cross Dec 28, 2023 to Mar 3, 202520
- Board memberRandall M. Toig Apr 10, 2018 to Mar 3, 202521
- Board memberWilliam S. Shanahan Jun 10, 2016 to Feb 28, 202522
- Board memberGeorge L. Fails Feb 17, 2015 to Apr 4, 201723
- Board memberJoseph J. Farnan Jr. Nov 9, 2015 to Jan 2, 201924
- Board memberMarkus Sieger Feb 21, 2014 to Mar 3, 202525
- Board memberN. Scott Fine Feb 21, 2014 to Jun 5, 202426
- Board memberFrancis Patrick Ostronic Apr 21, 2014 to Mar 3, 202527
- Board memberCe Rick Strattan Oct 28, 2010 to Mar 3, 202513
Former names
Timeline
Filings
232 filings to the SEC since October 2021: 7 annual reports, 10 quarterly reports, 40 major events, 129 insider forms, 3 large holders, 43 other. The latest 20:
- Apr 7, 202515-12G EDGAR
- Mar 26, 20258-K EDGAR
- Mar 26, 202525-NSE EDGAR
- Mar 24, 20258-K EDGAR
- Mar 6, 20258-K EDGAR
- Mar 3, 20254 EDGAR
- Mar 3, 20254 EDGAR
- Mar 3, 20254 EDGAR
- Mar 3, 20254 EDGAR
- Mar 3, 20254 EDGAR
- Mar 3, 20254 EDGAR
- Mar 3, 20254 EDGAR
- Feb 28, 20254 EDGAR
- Feb 14, 2025UPLOAD EDGAR
- Feb 4, 20258-K EDGAR
- Jan 13, 20254 EDGAR
- Jan 13, 20258-K EDGAR
- Jan 3, 20258-K EDGAR
- Dec 23, 20248-K EDGAR
- Dec 18, 2024CORRESP EDGAR
The 232 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 3 such filings since October 2021:
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARWilliam Conkling, Board member
- 19SEC EDGARVivien Wong, Board member
- 20SEC EDGARShawn Cross, Board member
- 21SEC EDGARRandall M. Toig, Board member
- 22SEC EDGARWilliam S. Shanahan, Board member
- 23SEC EDGARGeorge L. Fails, Board member
- 24SEC EDGARJoseph J. Farnan Jr., Board member
- 25SEC EDGARMarkus Sieger, Board member
- 26SEC EDGARN. Scott Fine, Board member
- 27